| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
barda_industry_day [2023/02/28 08:40]
liam [Participants] | barda_industry_day [2023/03/02 07:24] (current)
liam [Participants] |
|---|
| | [[Javan Esfandiari]] | CSTO | [[medical_technology_companies:Chembio Diagnostic Systems]] | | | [[Javan Esfandiari]] | CSTO | [[medical_technology_companies:Chembio Diagnostic Systems]] | |
| | [[Mark Eshoo]] | CSO | [[McDermott Will & Emery]] | | | [[Mark Eshoo]] | CSO | [[McDermott Will & Emery]] | |
| | | [[John Esker]] | Health Scientist, CBRN Division | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Denise Esposito]] | Partner | [[Covington & Burling]] | |
| | | [[John Etmekjian]] | - | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[Peter Eugster]] | Head of Hardware Engineering | [[medical_technology_companies:Karius]] | |
| | | [[Tyler Evans]] | Associate | [[Covington & Burling]] | |
| | | [[Pamela Evans]] | Emergency Management Specialist | [[Administration for Strategic Preparedness and Response]] (ASPR) | |
| | | [[Jason Ezzelle]] | Chief Commercial Officer | [[pharmaceutical_companies:Pharm-Olam]] | |
| | | [[Laure Fabrega]] | Director of Federal Policy | [[Biocom]] | |
| | | [[Tremel Faison]] | Regulatory Specialist, RQA | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Wensheng Fan]] | Executive Vice President and Chief Technology Officer | [[Spectral MD]] | |
| | | [[Rebecca Farkas]] | Director of External R&D | [[pharmaceutical_companies:GlaxoSmithKline]] | |
| | | [[Gerry Farrell]] | Chief Operating Officer | [[pharmaceutical_companies:FUJIFILM Diosynth Biotechnologies]] |
| | | [[Katie Favino]] | Quality Control Analyst | [[medical_technology_companies:Biotechnique]] | |
| | | [[Hannah Feldman]] | Public Affairs Specialist | [[Joint Project Manager for Medical Countermeasure Systems]] (JPM-MCS) | |
| | | [[Kathryn Feldmann]] | - | [[McKinsey & Company]] | |
| | | [[Gillian Fenton]] | Senior Counsel | [[pharmaceutical_companies:GlaxoSmithKline]] | |
| | | [[Nicholas Ferentinos]] | - | [[Stephen Gould Corporation]] | |
| | | [[Paula Fernandes]] | Founder and CEO | [[Global Scientific Systems for Health]] (GSSHealth) | |
| | | [[Christine Ferragine]] | Director of Government Affairs | [[pharmaceutical_companies:Biologics Resources]] | |
| | | [[Joe Figlio]] | - | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Erin Finehout]] | Project Manager | [[medical_technology_companies:Terumo Blood and Cell Technologies]] | |
| | | [[Rick Finnegan]] | - | - | |
| | | [[Marcie Finney]] | Executive Director | [[Cleveland Cord Blood Center]] | |
| | | [[Nathan Fisher]] | Head of Bacteriology | [[Southern Research Institute]] | |
| | | [[Ted Fitzgerald]] | Director of Global Research Services | [[FHI 360]] | |
| | | [[Amy Fix]] | Regulator Affairs | [[pharmaceutical_companies:Novavax]] | |
| | | [[Maggie Flynn]] | - | - | |
| | | [[Chaarles Fogelgren]] | - | [[pharmaceutical_companies:Med Fusion]] | |
| | | [[Robert Foley]] | - | [[medical_technology_companies:Medi-Immune]] | |
| | | [[Nicole Forrester]] | Executive Manager | [[CSIRO US]] | |
| | | [[Brian Fostet]] | CEO | [[pharmaceutical_companies:BioIncept]] | |
| | | [[Joseph Fountaine]] | Director of Information Technology | [[Lifescience Logistics]] | |
| | | [[Christopher Fox]] | Vice President of Formulations | [[Infectious Disease Research Institute]] | |
| | | [[Brandi France]] | Manager of Programs | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[Troy Francis]] | Contracting Officer | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Gregory Frank]] | - | [[Biotechnology Innovation Organization]] (BIO) | |
| | | [[Amie Franklin]] | CEO | [[medical_technology_companies:OxyBand Technologies]] | |
| | | [[Christopher Frech]] | SVP, Global Government Affairs | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[I.P. Freely]] | CEO | [[WonderWorks]] | |
| | | [[Douglas Freitag]] | Owner | [[Bayside Materials Technology]] | |
| | | [[Valerie Fremont]] | CSO | [[medical_technology_companies:Quality Biological]] | |
| | | [[Michael Friend]] | Principal Investigator | [[Intellectual Ventures Laboratory]] | |
| | | [[Bob Fritzen]] | - | [[medical_technology_companies:Caprion Biosciences]] | |
| | | [[Phyllis Frosst]] | Global Director of Health Policy | [[pharmaceutical_companies:Seqirus]] | |
| | | [[Jeffrey Froude]] | - | [[Defense Threat Reduction Agency]] (DTRA) | |
| | | [[Kate Fry]] | CEO | [[America's Blood Centers]] | |
| | | [[Robert Fuentes]] | Senior Director of Medical Information | [[pharmaceutical_companies:Novavax]] | |
| | | [[Nick Fullenkamp]] | Senior Director of Corporate Development | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[Ryan Fung]] | - | [[PRA Health Sciences]] | |
| | | [[Carrie-Lynn Furr]] | Vice President of Regulatory Affairs | [[pharmaceutical_companies:AmpliPhi Biosciences]] | |
| | | [[Joan Fusco]] | CDO | [[pharmaceutical_companies:Crozet BioPharma]] | |
| | | [[Rachel Fybel]] | - | [[United States House of Representatives]] | |
| | | [[Alexis Gabard]] | Director of Programs | [[pharmaceutical_companies:Keratin Biosciences]] | |
| | | [[Maryann Gallivan]] | President and CEO | [[Tunnell Consulting]] | |
| | | [[Yonghong Gao]] | Statistician (Biology) | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Neal Gapinski]] | Vice President | [[pharmaceutical_companies:CritiTech]] | |
| | | [[Efrain Garcia]] | Health Scientist | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Darin Gardner]] | Partner | [[Jochum Shore & Trssevin]] | |
| | | [[Joseph Gariano]] | Consultant | [[Core Solutions]] | |
| | | [[Michael Gayle]] | Business Development Manager - DoD Growth Market | [[SRI International]] | |
| | | [[Cohava Gelber]] | Executive Chairperson | [[pharmaceutical_companies:Serpin Pharma]] | |
| | | [[Bruce Gellin]] | President of Global Immunization | [[Sabin Vaccine Institute]] | |
| | | [[Amir Genosar]] | CEO | [[pharmaceutical_companies:Aktivax]] | |
| | | [[Dylan George]] | Associate Director | [[In-Q-Tel]] | |
| | | [[Sandra George]] | Director of Grants and Contracts | [[pharmaceutical_companies:Emergent BioSolutions]] | |
| | | [[Joseph Gerstner]] | Vaccine and Biological Development | [[Biomedical Advanced Research and Development Authority]] (BARDA) | |
| | | [[Abdi Ghaffari]] | Vice President of Preclinical Research | [[pharmaceutical_companies:AIT Therapeutics]] | |
| | | [[Kaushik Ghosal]] | Director of Business Development | [[BioMotiv]] | |
